Regenxbio Inc (RGNX)
US$ 9.16-0.43%
Price Chart
Key Statistics
Market Cap
$ 422.76M
P/E Ratio
0.00
Revenue (TTM)
$ 156.72M
Volume
601.22K
52W High
$ 15.36
52W Low
$ 5.04
Dividend Yield
0.00%
Beta
1.09
Technicals
50-Day MA
8.8536
200-Day MA
8.678
52 Week High
15.36
52 Week Low
5.035
About RGNX
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.
Employees
353
Headquarters
Rockville, MD
CEO
Mr. Curran M. Simpson M.S.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg